Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
There are controversies whether Minimal Change Disease (MCD) and Focal and Segmental Glomerulosclerosis (FSGS) are distinct glomerular lesions or different manifestations within the same spectrum of diseases. The uPAR (urokinase-type plasminogen activator receptor) and some slit diaphragm proteins m...
Main Authors: | Lívia Helena de Morais Pereira, Crislaine Aparecida da Silva, Maria Luíza Gonçalves Dos Reis Monteiro, Liliane Silvano Araújo, Laura Penna Rocha, Marcelo Bernardes da Rocha Reis, Fernando Silva Ramalho, Rosana Rosa Miranda Corrêa, Marcos Vinicius Silva, Marlene Antonia Reis, Juliana Reis Machado |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0217569 |
Similar Items
-
In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
by: Crislaine Aparecida da Silva, et al.
Published: (2020-01-01) -
Evaluation of the Diagnostic Potential of uPAR as a Biomarker in Renal Biopsies of Patients with FSGS
by: Crislaine Aparecida da Silva, et al.
Published: (2019-01-01) -
Renal Biopsy: Use of Biomarkers as a Tool for the Diagnosis of Focal Segmental Glomerulosclerosis
by: Crislaine Aparecida da Silva, et al.
Published: (2014-01-01) -
Focal and Segmental Glomerulosclerosis and Membranous Nephropathy overlapping in a patient with Nephrotic Syndrome: a case report
by: Crislaine Aparecida da Silva, et al.
Published: (2019-02-01) -
Familial Focal Segmental Glomerulosclerosis With Late-Onset Presentation and R229Q/R291W Podocin Mutations
by: Michelle T. P. Riguetti, et al.
Published: (2020-09-01)